2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
作者： Valentin Fuster , Lars E. Rydén , Davis S. Cannom , Harry J. Crijns , Anne B. Curtis
DOI: 10.1016/J.JACC.2010.09.013
关键词:
摘要: Developed in partnership with the Heart Rhythm Society L. Samuel Wann, MD, MACC, FAHA, Chair[‡][1]; Anne B. Curtis, FACC, FAHA[‡][1],[§][2]; Kenneth A. Ellenbogen, FHRS[†][3],[§][2]; N.A. Mark Estes III, FHRS[∥][4]; Michael D. Ezekowitz, MB, ChB, FACC[‡][1];
elsevier.com
onlinejacc.org 参考文章(907)
DanielL Dries, DerekV Exner, BernardJ Gersh, MichaelJ Domanski, MyronA Waclawiw, LynneW Stevenson, Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials Journal of the American College of Cardiology. ,vol. 32, pp. 695- 703 ,(1998) , 10.1016/S0735-1097(98)00297-6
Gerald V Naccarelli, Deborah L Wolbrette, Mazhar Khan, Luna Bhatta, John Hynes, Soraya Samii, Jerry Luck, Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials American Journal of Cardiology. ,vol. 91, pp. 15- 26 ,(2003) , 10.1016/S0002-9149(02)03375-1
Eric N. Prystowsky, D. Woodrow Benson, Valentin Fuster, Robert G. Hart, G. Neal Kay, Robert J. Myerburg, Gerald V. Naccarelli, D. George Wyse, Management of Patients With Atrial Fibrillation A Statement for Healthcare Professionals From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association Circulation. ,vol. 93, pp. 1262- 1277 ,(1996) , 10.1161/01.CIR.93.6.1262
P A Boyden, L P Tilley, A Albala, S K Liu, J J Fenoglio, A L Wit, Mechanisms for atrial arrhythmias associated with cardiomyopathy: a study of feline hearts with primary myocardial disease. Circulation. ,vol. 69, pp. 1036- 1047 ,(1984) , 10.1161/01.CIR.69.5.1036
Y. A. Lee, C. S. Liang, M. A. Lee, K. Lindpaintner, Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: a comprehensive study of all its components in the dog Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 11035- 11040 ,(1996) , 10.1073/PNAS.93.20.11035
Leendert M. van Wijk, Peter den Heijer, Harry J. Crijns, Wiek H. van Gilst, Kong I. Lie, Flecainide versus quinidine in the prevention of paroxysms of atrial fibrillation. Journal of Cardiovascular Pharmacology. ,vol. 13, pp. 32- 36 ,(1989) , 10.1097/00005344-198901000-00005
Raffaele Baroffio, Guido Tisi, Fabio Guzzini, Elisabetta Milvio, Pierluigi Annoni, A Randomised Study Comparing Digoxin and Propafenone in the Treatment of Recent Onset Atrial Fibrillation Clinical Drug Investigation. ,vol. 9, pp. 277- 283 ,(1995) , 10.2165/00044011-199509050-00005
R.G. Hart, L.A. Pearce, V.T. Miller, D.C. Anderson, J.F. Rothrock, G.W. Albers, E. Nasco, Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovascular Diseases. ,vol. 10, pp. 39- 43 ,(2000) , 10.1159/000016023
Suneet Mittal, Shervin Ayati, Kenneth M. Stein, David Schwartzman, Doris Cavlovich, Patrick J. Tchou, Steven M. Markowitz, David J. Slotwiner, Marc A. Scheiner, Bruce B. Lerman, Transthoracic Cardioversion of Atrial Fibrillation Comparison of Rectilinear Biphasic Versus Damped Sine Wave Monophasic Shocks Circulation. ,vol. 101, pp. 1282- 1287 ,(2000) , 10.1161/01.CIR.101.11.1282
Paul A Friedman, John H Ip, Mohammad Jazayeri, John H Lobban, Brian Olshansky, Duo Zhou, Tracy Knowles, David E Euler, RID-AF Investigators, The impact of atrial prevention and termination therapies on atrial tachyarrhythmia burden in patients receiving a dual-chamber defibrillator for ventricular arrhythmias. Journal of Interventional Cardiac Electrophysiology. ,vol. 10, pp. 103- 110 ,(2004) , 10.1023/B:JICE.0000019263.75856.21